|
Oligonucleotide sequences used for EMSA. For every SNP, 4 oligonucleotides (2 complimentary pairs) were synthesized, one pair for each allele. One oligonucleotide sequence from each pair had additional GG dinucleotide overhangs at the 5'end for fill-in labeling reaction. Care was taken to make sure that the additional GG-dinucleotide did not influence the predicted TF binding capability. The complementary sequences lacked the GG pairs. Only the allelic sequence predicted to bind most stably was chosen for the fill-in labeling reaction (marked *) while the gel shift assays were carried out using competitor with a perfect match versus a competitor with the allelic mismatch. The polymorphic site is underlined. Column 'Ratio' shows the difference in competition between the labeled and non-labeled oligomers at 25-fold excess, by dividing Allele2 (x25) values by Allele1 (x25). |
||||||||||||
| Gene name and rs ID |
Sequence |
Allele 1(competitor oligo is a perfect match) |
Allele 2 (competitor oligo has a mismatch) |
Ratio |
||||||||
| x5 |
x10 |
x15 |
x20 |
x25 |
x5 |
x10 |
x15 |
x20 |
x25 |
|||
|
|
||||||||||||
| Serotonin receptor (5-HT-1A) rs968554 ENST00000323865 |
GGAAAAGAATCCA CTTGGGCCAATG * GGAAAAGAATCCA GTTGGGCCAATG |
1.29 |
- |
1.27 |
1.23 |
1.00 |
1.16 |
- |
1.12 |
1.13 |
0.96 |
0.96 |
| Dopamine receptor DRD1 rs267412 ENST00000329144 |
GGAATGTAAACCC AACACAAAAG * GGAATGTAAGCCC AACACAAAAG |
0.72 |
- |
- |
0.54 |
0.56 |
0.98 |
- |
1.06 |
1.03 |
1.12 |
2.05 |
| Dopamine receptor DRD1 rs267413 ENST00000329144 |
GGTATAAAAGTCA GTGAATACAG * GGTATAAAAGTCT GTGAATACAG |
0.96 |
- |
0.81 |
0.74 |
0.81 |
0.97 |
- |
0.98 |
0.97 |
1.01 |
1.24 |
| Muscarinic acetylcholine receptor M1 rs509813 ENST00000306960 |
GGCTTGGGCTCCT CCCCCCAGCCAAC * GGCTTGGGCTCCT CCCGCCAGCCAAC |
0.21 |
0.11 |
0.08 |
0.05 |
0.09 |
0.70 |
0.60 |
0.46 |
0.46 |
0.37 |
4.11 |
| Follicle stimulating hormone receptor. rs2882225 ENST00000304421 |
GGCAAGGGAGCTG TTTTTTTT GGCAAGGGAGCTT TTTTTTTT * |
1.10 |
1.00 |
0.86 |
0.71 |
0.75 |
1.96 |
1.73 |
1.67 |
1.36 |
1.35 |
1.80 |
| Adenosine-A3 receptor. rs1538251 ENST00000241356 |
GGTGGCCACCAGA GGGCAGCACG * GGTGGCCACCAGA GGGAAGCACG |
1.08 |
1.11 |
0.95 |
0.89 |
0.76 |
1.49 |
1.41 |
1.44 |
1.51 |
1.40 |
1.84 |
| Bradykinin receptor B2 rs1800508 ENST00000306005 |
GGGAAGTGCCCAG GAGGC * GGGAAGTGCTCAG GAGGC |
1.67 |
1.28 |
1.17 |
1.16 |
1.20 |
1.10 |
1.06 |
1.11 |
1.27 |
1.33 |
1.03 |
| Bradykinin receptor B2 rs945032 ENST00000306005 |
GGTTCCTGGGTGC GGG * GGTTCCTGGGTAC GGG |
0.88 |
0.72 |
0.72 |
0.62 |
0.55 |
1.15 |
1.22 |
1.29 |
1.22 |
1.27 |
2.30 |
| Bradykinin receptor B2 rs1799722 ENST00000306005 |
GGCTGGGTAGTGA TGTCATCAGC GGCTGGGTAATGA TGTCATCAGC * |
0.36 |
0.21 |
0.16 |
0.12 |
0.12 |
0.50 |
0.29 |
0.22 |
0.20 |
0.20 |
1.66 |
| Calcitonin receptor precursor rs2528521 ENST00000316576, ENST00000248548 |
GGCTGTCCCCGGA GTGGCGGCT GGCTGTCCCCGGA GTGACGGCT * |
0.54 |
0.36 |
0.25 |
0.22 |
0.21 |
0.90 |
0.83 |
0.73 |
0.60 |
0.55 |
2.62 |
Mottagui-Tabar et al. BMC Genomics 2005 6:18 doi:10.1186/1471-2164-6-18 |
||||||||||||